Medicamen Biotech Ltd (MEDICAMEQ) Shareholding Pattern - Promoter, FII, DII & Public Holdings
As of Jun 2026, promoters held 40.46% of Medicamen Biotech Ltd, FIIs 0.07%, DIIs 0.4%, government 0.05% and the public 59.01%, across 11,047 shareholders.
| Metric | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 42.99% | 42.99% | 43.16% | 40.46% | 40.46% | 40.46% | 40.46% | 40.46% |
| FIIs | 0.06% | 0.06% | 0.12% | 0% | 0.05% | 0.02% | 0.1% | 0.07% |
| DIIs | 1.17% | 0.87% | 0.69% | 0.64% | 0.59% | 0.44% | 0% | 0.4% |
| Government | 0% | 0.06% | 0.06% | 0.05% | 0.05% | 0.05% | 0.05% | 0.05% |
| Public | 55.79% | 56.04% | 55.99% | 58.83% | 58.84% | 59.02% | 59.39% | 59.01% |
| No. of Shareholders | 10,792 | 10,576 | 10,435 | 10,808 | 11,177 | 10,967 | 10,806 | 11,047 |